Synmosa Biopharma Corporation (TPEX:4114)
30.90
-0.05 (-0.16%)
Apr 28, 2026, 1:30 PM CST
7.38% (1Y)
| Market Cap | 15.54B |
| Revenue (ttm) | 6.19B |
| Net Income (ttm) | 821.85M |
| Shares Out | 502.77M |
| EPS (ttm) | 1.66 |
| PE Ratio | 18.61 |
| Forward PE | n/a |
| Dividend | 0.55 (1.76%) |
| Ex-Dividend Date | Jul 11, 2025 |
| Volume | 563,297 |
| Average Volume | 834,311 |
| Open | 30.95 |
| Previous Close | 30.95 |
| Day's Range | 30.70 - 31.00 |
| 52-Week Range | 28.82 - 39.80 |
| Beta | 0.02 |
| RSI | 40.44 |
| Earnings Date | Aug 28, 2026 |